Table 3.

Comparisons of demographic data and clinical features of patients of RL-LDLT who underwent RYHJ

Demographic and clinical features	Success group (n = 15)	Restenosis group (n = 4)	p
	Median (IQR)	Median (IQR)
Recipient age (years)	50.0 (47.0–57.0)	54.5 (50.0–58.3)	0.596
MELD score	13.0 (10.0–19.5)	10.0 (8.3–15.0)	0.411
Cold ischemia time (min)	66.0 (59.5–104.0)	96.5 (88.3–105.8)	0.307
Warm ischemia time (min)	21.0 (17.0–24.0)	17.5 (11.5–21.3)	0.469
Anhepatic phase time(min)	29.0 (23.5–49.0)	26.5 (24.0–31.5)	0.469
Transplantation blood loss (ml)	3500.0 (1650.0–5200.0)	1250.0 (1025.0–1425.0)	0.124
Transplantation operative time (min)	365.0 (332.5–390)	375.0 (348.8–390.0)	0.961
Hepaticojejunostomy blood loss (ml)	300.0 (200.0–600.0)	250.0 (212.5–275.0)	0.411
Hepaticojejunostomy operative time (min)	250.0 (220.0–282.5)	255.0 (238.8–266.3)	0.961
Post Transplantation length (month)	14.5 (10.3–27.0)	29.3 (24.6–35.6)	0.185
	n (%)	n (%)
Gender			0.097
Male	14 (93.3)	2 (50.0)
Female	1 (6.7)	2 (50.0)
Bile leak			0.603
Yes	7 (46.7)	1 (25.0)
No	8 (53.3)	3 (75.0)
Bile duct anastomosis orifice			0.108
1	11 (73.3)	1 (25.0)
2	3 (20.0)	3 (75.0)
3	1 (6.7)	0 (0)
Type of bile duct anastomosis			1.000
D-G	9 (60.0)	3 (75.0)
D-D	6 (40.0)	1 (25.0)
T-Tube placement			0.530
Yes	4 (26.7)	0 (0)
No	11 (73.3)	4 (100)
Hepatic artery complications			0.530
Yes	2 (13.3)	1 (25.0)
No	13 (86.7)	3 (75.0)
IHD stone			0.255
Yes	9 (60.0)	4 (100)
No	6 (40.0)	0 (0)
ABO incompatibility			0.097
Yes	1 (6.7)	2 (50.0)
No	14 (93.3)	2 (50.0)
Rejection			0.557
Yes	4 (26.7)	2 (50.0)
No	11 (73.3)	2 (50.0)
Survival			0.530
Alive	10 (66.7)	4 (100.0)
Death	5 (33.3)	0(0)

RL-LDLT Right lobe living donor liver transplantation, RYHJ Roux-en-Y hepaticojejunostomy, IQR Interquartile range, MELD Model for end-stage liver disease, D-G Duct-to-Glissonean sheath anastomosis, D-D Duct-to-duct anastomosis, IHD Intrahepatic duct